BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28385011)

  • 1. Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with
    Zhang L; Zhao L; Liu Y; Liu J; Li X
    J Vet Sci; 2017 Dec; 18(4):431-437. PubMed ID: 28385011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
    Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
    J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
    Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
    N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
    [No Abstract]   [Full Text] [Related]  

  • 4. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs.
    Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ
    BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics.
    Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y
    J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics.
    Ling Z; Yonghong L; Junfeng L; Li Z; Xianqiang L
    J Vet Pharmacol Ther; 2018 Apr; 41(2):307-313. PubMed ID: 29139136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model.
    Zhao Y; Guo LL; Fang B; Liu B
    PLoS One; 2018; 13(12):e0209177. PubMed ID: 30596709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
    Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
    BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Haemophilus parasuis and Histophilus somni from pigs and cattle in Denmark.
    Aarestrup FM; Seyfarth AM; Angen Ø
    Vet Microbiol; 2004 Jun; 101(2):143-6. PubMed ID: 15172697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Haemophilus parasuis from healthy pigs in China.
    Zhang P; Zhang C; Aragon V; Zhou X; Zou M; Wu C; Shen Z
    Vet Microbiol; 2019 Apr; 231():40-44. PubMed ID: 30955821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations.
    Vilalta C; Giboin H; Schneider M; El Garch F; Fraile L
    J Vet Pharmacol Ther; 2014 Dec; 37(6):542-9. PubMed ID: 24903473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response.
    Macedo N; Cheeran MC; Rovira A; Holtcamp A; Torremorell M
    Vet Microbiol; 2017 Feb; 199():91-99. PubMed ID: 28110792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tilmicosin after oral administration in swine.
    Shen J; Li C; Jiang H; Zhang S; Guo P; Ding S; Li X
    Am J Vet Res; 2005 Jun; 66(6):1071-4. PubMed ID: 16008233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
    Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
    BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamithromycin in swine: Pharmacokinetics and clinical evaluation against swine respiratory disease.
    Hamel D; Richard-Mazet A; Voisin F; Böhne I; Fraisse F; Rauh R; Huang R; Kellermann M; Letendre L; Dumont P; Rehbein S
    Vet Med Sci; 2021 Mar; 7(2):455-464. PubMed ID: 33058489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness of tilmicosin in respiratory diseases of swine].
    Binder S; Le NB; Berner H; Bauer J
    Berl Munch Tierarztl Wochenschr; 1993 Jan; 106(1):6-9. PubMed ID: 8431202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior infection with Bordetella bronchiseptica increases nasal colonization by Haemophilus parasuis in swine.
    Brockmeier SL
    Vet Microbiol; 2004 Mar; 99(1):75-8. PubMed ID: 15019114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling of Haemophilus parasuis SH0165 response to tilmicosin.
    Liu Y; Chen P; Wang Y; Li W; Cheng S; Wang C; Zhang A; He Q
    Microb Drug Resist; 2012 Dec; 18(6):604-15. PubMed ID: 22935051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel experimental intraperitoneal infection model for Haemophilus parasuis in neutropenic guinea pigs.
    Zhao YD; Liu BT; Guo LL; Shan H; Fang BH
    J Pharmacol Toxicol Methods; 2019; 95():27-35. PubMed ID: 30476621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.